Connect with us

Hi, what are you looking for?

Stock

Balance of risks still ‘decently positive’ for China stocks- Gavekal Research

Investing.com– The balance of risks towards Chinese stocks still remained positive, Gavekal Research said in a note, even as a Donald Trump presidency and middling stimulus measures made for more headwinds.

Gavekal noted that Trump’s election victory, which heralds more tariffs, as well as disappointing fiscal measures from the National People’s Congress, should have battered local stocks.

But the Shanghai Shenzhen CSI 300 and the Shanghai Composite logged limited losses over the past week, even briefly gaining. Gavekal said this indicated some resilience in local risk appetite. 

“This blithe response by local investors to what could have been a major disappointment suggests that the Chinese equity bull market has plenty of support and further room to run,” Gavekal Research wrote in a note. 

The brokerage noted that the biggest risk to China’s stock rally this year was the prospect of higher tariffs under a Trump presidency, the chances of which had doubled after his election victory. Trump has vowed to impose an at least 60% tariff on all Chinese imports, which bodes poorly for the country. Gavekal said the new round of tariffs would be far more painful for China than those imposed during Trump’s first term.

But the balance of risks still remained “decently positive” for Chinese stocks, Gavekal said, stating that the country was in the early stages of a stimulus cycle. Recent government measures to directly support equity prices also bode well for local markets. 

China’s bluechip CSI 300 index is trading up nearly 21% so far in 2024, with a bulk of these gains coming in late-September after Beijing announced its most aggressive stimulus measures in recent years. 

Commodities less positive from China perspective

Gavekal Research noted that while Chinese equities remained resilient, the same could not be said for commodity prices, specifically that they would likely not benefit all that much from Chinese stimulus measures.

The brokerage noted that China’s recent stock rally had not been accompanied by a run-up in commodity prices, especially those of iron ore and copper

“The fundamental problem for investors looking to play the stimulus through commodities is that China’s policy package is not designed for a maximal—or so far, even moderate—boost to short-term materials demand,” Gavekal Research wrote in a note. 

The brokerage said that China’s recent round of stimulus was aimed more at improving local liquidity, stabilizing property markets and addressing local government debt. The measures did not appear to be aimed at increasing infrastructure and property development, which has fueled Chinese commodity demand in the past.

This post appeared first on investing.com

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

    Economy

    LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

    Editor's Pick

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Latest News

    Warner Bros. Discovery said Thursday its streaming platform Max added 7.2 million global subscribers in the third quarter. It marked the biggest quarterly growth for...

    Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 beneficialinvestmentnow.com